ROME — The global push toward eco-friendly and circular economy models is facing a critical bottleneck as a major United Nations food security body issued an international warning regarding recycled food packaging. In its latest comprehensive scientific review, titled “Food safety implications of recycled plastics and alternative food contact materials,” the agency cautioned that the rapid adoption of recycled plastics and bio-based containers is outpacing existing food safety controls. The report emphasizes that without stricter, data-backed decontamination protocols, recycled materials can introduce unexpected chemical contaminants directly into the global food supply chain. The Chemistry of Recycled ContaminationWhile newly manufactured “virgin” plastics operate…
Author: Surendrakumar Bajpai
“Forever Traumatized”: Florida Surgeon Breaks Silence After Fatal Wrong-Organ Error MIRAMAR BEACH — A Florida surgeon facing manslaughter charges for fatally removing a patient’s liver instead of his spleen has broken his silence, describing himself as “forever traumatized” by the event. In a chilling 400-page deposition recently reviewed by legal authorities, Dr. Thomas Shaknovsky, 44, offered a visceral account of the August 2024 operating room disaster that claimed the life of 70-year-old Navy veteran William Bryan. Shaknovsky, who was arrested in April 2026 while working as a Lyft driver, claimed that a series of “difficult circumstances”—including profuse internal bleeding and an…
New Delhi : the Central Board of Direct Taxes (CBDT) had directed that the doctors or the hospital in which the doctors work has to pay 10 percent tax deducted at source (TDS) on free samples and other gifts worth more than Rs 20,000 if they are given to them for free. This is required by the Income-tax Act of 1961, Section 194R (TDS on benefit or perk related to business or profession).But Section 194R does not speak about penalties and prosecution of what will be the consequences of if someone who didn’t pay or didn’t follow the rules in…
New Delhi : In a move that could open another legal worry for the doctors, the centre has proposed to amend the National Medical Commission (NMC) Act 2019. If approved, the amendment would allow patients and their relatives to approach the Ethics and Medical Registration Board (EMRB) or the NMC against the decision of the State Medical Council in complaints related to medical negligence.Till now, appeals of only doctors who were found guilty of medical negligence by the EMRB were taken up by the NMC and would overlook similar claims made by patients or their families. This was despite a Supreme Court…
New Delhi : The National Medical Commission (NMC) has stated that using unproven stem cell therapy to treat autistic children will be treated as “professional misconduct” indicating that it makes doctors liable for punitive action in case of violation. For the first time, the regulator for doctors in India has recognised the problem of predatory marketing of stem cell therapies to treat autism. The indiscriminate promotion has led to the creation of false hopes, unrealistic expectations, and exploitation of autistic children and their families. Until now, the ambiguity around the controversial therapy allowed some doctors and companies to subject hundreds…
New Delhi : The Ministry of health and family welfare (Mohfw) has decided to constitute a committee of seven membersto prepare the “national drugs database”. The committee will give recommendations and prepare a comprehensive database of drug formulations manufactured and marketed in the country, providing detailed information on a drug, its dosage form, strength, and details of the manufacturer, marketer, or importer of the drug. The database will not only “empower consumers” but will also improve the “monitoring mechanism” for the quality of drugs in circulation across the country and the “uniform administration” of the regulatory system.The members of the…
New Delhi : Country’s drug controller General of India (DCGI) has written a strongly worded letter to Rogerio Gaspar, Director, Regulation and Prequalification, WHO informing that all control samples of the products have been found to be complying with specifications. Government’s Central Drug Laboratory (CDL) which conducted quality tests on the samples lifted from Maiden pharmaceuticals – the Sonepat-based company which has been in the dock for allegedly causing deaths of children in Gambia has found the products to be complying with specifications, putting the onus on World Health Organisation (WHO) for “prematurely” blaming an Indian company for the deaths…
The Pharmacy Council of India (PCI) has directed all the state and Union territory (UT) governments and state pharmacy councils to take steps to immediately implement the Pharmacy Practice Regulations (PPR), 2015, notified by the Council in January 2015. PCI has shared the letter received from the ministry of health and family welfare (MoHFW) clarifying the procedures for implementation of the regulation in the states, considering education is on the concurrent list. The MoHFW clarified that the state government may declare that the regulations shall take effect in the state at any time after the constitution of the state pharmacy…
Washington : US health regulators approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood clotting disorder, making it the world’s most expensive drug. The drug costs 28.58 crores (28,58,48,675.00) in Indian rupees. The Food and Drug Administration, USA cleared drugmaker CSL Behring’s Hemgenix-hemophilia B gene therapy, an IV treatment for adults with hemophilia B, the less common form of the genetic disorder which primarily affects men.
New Delhi : The Income Tax Appellate Tribunal(ITAT) has recently observed in a major denial of relief against Mankind Pharma Ltd. that freebies given to doctors are illegal and do not fall under the head “Business Promotion Expenses”. The bench comprising of Anil Chaturvedi and Challa Nagendra Prasad disallowed the sales promotion expenses incurred by Mankind Pharma Ltd on account of freebies given to doctors and disallowed a claim of Rs. 1,06,78,600/- The Tribunal considered the nature of promotion expenses to decide whether the addition by the Assessing Officer(AO) was justified. The AO, during the assessment proceedings had noticed that…
